What are all the uses of Phenytoin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Uses of Phenytoin

Phenytoin is primarily used for treating epilepsy, particularly generalized tonic-clonic seizures, partial seizures with or without generalization, and status epilepticus, with its primary mechanism of action being the modulation of voltage-gated sodium channels in neuronal cell membranes. 1, 2

Primary Indications

  • Seizure Management:

    • Generalized tonic-clonic seizures
    • Partial seizures (simple partial, complex partial)
    • Status epilepticus (as part of treatment protocol)
    • Serial seizures
  • Specific Clinical Scenarios:

    • Seizure prophylaxis after subarachnoid hemorrhage
    • Management of seizures in alcohol withdrawal
    • Treatment of refractory status epilepticus (high-dose phenytoin up to 30 mg/kg)

Dosing Protocols

Adult Dosing

  • Standard maintenance dosage: 300-400 mg/day (typically one 100-mg capsule three to four times daily)
  • Once-daily dosing option: 300 mg daily (only with extended phenytoin sodium capsules)
  • Loading dose: 1 gram divided into three doses (400 mg, 300 mg, 300 mg) administered at two-hour intervals in controlled settings 1

Pediatric Dosing

  • Initial dose: 5 mg/kg/day in two or three equally divided doses
  • Maintenance dose: 4-8 mg/kg/day (maximum 300 mg daily)
  • Children >6 years: May require minimum adult dose (300 mg/day) 1

Status Epilepticus Dosing

  • Standard dose: 18-20 mg/kg IV with 56% success rate
  • High-dose option: Up to 30 mg/kg (as recommended by the Epilepsy Foundation of America's Working Group) before switching to alternative agents 3, 4

Pharmacokinetics

  • Plasma half-life: Averages 22 hours (range 7-42 hours)
  • Steady-state achievement: 7-10 days after initiation of therapy
  • Protein binding: 90-95% protein-bound in plasma
  • Therapeutic serum levels: 10-20 mcg/mL
  • Metabolism: Almost completely metabolized in the liver 1, 2

Comparative Efficacy

  • Phenytoin shows comparable efficacy to valproate for partial onset seizures and generalized tonic-clonic seizures 5
  • In status epilepticus, phenobarbital has shown equal efficacy when compared with lorazepam, phenytoin, and phenytoin plus diazepam 3

Administration Routes

  • Oral: Extended capsules, prompt capsules, suspension
  • Intravenous: Direct IV administration (requires careful monitoring)
  • Intramuscular: Fosphenytoin (prodrug) can be administered IM with complete absorption and rapid conversion to phenytoin 6

Monitoring Requirements

  • Serum level monitoring: Recommended when:
    • Initiating therapy (after 7-10 days)
    • Changing dosage
    • Adding/removing other medications
    • Suspecting toxicity or non-compliance
  • Trough levels: Obtained just before next scheduled dose
  • Peak levels: 4-12 hours after administration 1

Adverse Effects and Cautions

  • Neurological: Phenytoin encephalopathy, cognitive impairment, cerebellar syndrome
  • Cardiovascular: Hypotension, cardiac dysrhythmias
  • Local reactions: Purple glove syndrome (with IV administration)
  • Long-term concerns: Not recommended for patients with:
    • Loss of locomotion
    • Marked cognitive impairment
    • Symptoms of cerebellar disease
    • Intellectual disability (may exacerbate balance disturbances) 4, 2

Special Considerations

  • Saturation kinetics at high plasma levels can lead to disproportionate increases in serum levels with small dose increases
  • Careful monitoring needed when switching between different phenytoin formulations due to differences in bioavailability
  • Not recommended as first-line therapy except in status epilepticus management 1, 2

Phenytoin's primary mechanism of action involves inhibiting voltage-sensitive sodium channels in the plasma membrane of neurons, which stabilizes the threshold against hyperexcitability and prevents the spread of seizure activity 7.

AI Assistant: I've provided a comprehensive overview of phenytoin's uses, focusing on its primary role in seizure management while including important information about dosing, monitoring, and safety considerations.

References

Research

Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.

Journal of intellectual disability research : JIDR, 1998

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Status Epilepticus and Pediatric Sedation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Basis of the antiseizure action of phenytoin.

General pharmacology, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.